查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1701637

Quetiapine中间体化学品市场规模、份额、趋势分析报告：按产品、最终用途、地区、细分市场预测，2025-2030 年

Quetiapine Intermediate Chemicals Market Size, Share & Trends Analysis Report By Product (1-[2-(2-Hydroxyethoxy)ethyl] Piperazine, Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one), By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

Quetiapine中间体化学品市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球Quetiapine中间体化学品市场规模预计到2030年将达到658亿美元，2025年至2030年期间的复合年增长率为4.9%。

主要驱动因素是全球精神疾病发生率上升，对Quetiapine的需求增加，导致对其中间体的需求增加。非专利喹硫平生产的成本效益，尤其是在新兴市场，直接推动了对高效中间体合成的需求。此外，包括新配方和输送系统在内的药物创新需要这些化学构件的稳定供应。

思觉失调症和躁郁症等精神疾病的全球负担是一个重要驱动因素。人们的认识和诊断不断提高，对Quetiapine有效治疗的需求也不断增长。紧张的生活方式、社会经济因素和人口老化都导致精神疾病盛行率上升。

原厂药喹Quetiapine的专利已经到期，为学名药​​製造商打开了市场。这导致竞争加剧和对成本效益生产的重视，直接影响了对廉价中间化学品的需求。製药公司正在不断研究和开发喹Quetiapine的新配方，包括缓释性和新的输送系统。此类研发活动需要稳定供应高品质的中间体。

精神疾病盛行率的不断上升直接推动了对Quetiapine的医药需求，从而增加了对其中间体化学品的需求。对具有成本效益的学名药生产的推动迫使製药公司有效率地采购这些中间体。专注于新型Quetiapine平製剂和输送系统的药物研发工作进一步促进了对这些关键化学构件的需求不断增长。

由于医疗支出不断增加以及精神疾病盛行率不断上升，亚太地区製药业正在经历快速增长，这极大地推动了对Quetiapine的需求。该地区专注于学名药生产以提供价格合理的药品，这直接推动了对具有成本效益的Quetiapine中间体的需求。此外，亚太地区对本地医药研发的投资不断增加，也促进了对这种重要化学前驱物的需求不断增长。

Quetiapine中间体化学品市场报告重点

  • 根据最终用途，预计到 2024 年，製药部门将占据最大的收益占有率，达到 85.5%。思觉失调症和躁郁症等精神疾病的盛行率不断上升，推动了对Quetiapine的需求，进而推动了对中间体化学物质的需求。
  • 按产品划分，二苯并[b,f][1,4]硫氮杂卓-11(10 H)-酮类产品在 2024 年占据最大收益占有率，为 35.2%，预计在预测期内将继续占据行业主导地位。它是Quetiapine合成的关键中间体，形成核心环结构。其生产效率直接影响Quetiapine的产量，进而影响所有上游中间体的需求。
  • 按地区划分，亚太地区将在 2024 年占据 50.7% 的收入份额。由于医疗支出增加和精神障碍盛行率上升，亚太地区的製药业正在经历快速增长，从而推动了对Quetiapine中间体的需求。
  • 2024 年 12 月，Ami Organics 开始在其位于中国河北省沧州工厂建设第二条生产线，生产多功能添加剂 Nylostab S-EED。此次扩建是与北京天康助剂有限公司合作进行的，旨在满足中国尼龙产业日益增长的需求，特别是纺织、汽车和包装产业的需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

  • Quetiapine中间体化学品的全球市场展望
  • 价值链分析
    • 原料展望
    • 工业冷冻/产品展望
    • 销售管道分析
  • 价格趋势分析
    • 影响价格的因素
  • 法律规范
    • 标准与合规性
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场问题分析
    • 市场机会分析
  • 波特五力分析
    • 供应商的议价能力
    • 买家的议价能力
    • 替代威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTLE分析
    • 政治的
    • 经济
    • 社会状况
    • 产品
    • 环境
    • 合法的

第四章Quetiapine平中间体化学品市场：按产品进行的估计和趋势分析

  • Quetiapine中间体化学品市场：2024 年及 2030 年产品差异分析
  • 1-[2-(2-羟基乙氧基)乙基]Piperazine
  • 二苯并[b,f][1,4]硫氮杂卓-11(10H)-酮
  • 其他产品

第五章Quetiapine中间体化学品市场：按最终用途的估计和趋势分析

  • Quetiapine中间体化学品市场：2024 年和 2030 年最终用途变化分析
  • 製药
  • 其他用途

第六章Quetiapine中间体化学品市场：区域评估与趋势分析

  • 2024年及2030年区域分析
  • 北美洲
    • 按产品，2018-2030
    • 依最终用途，2018-2030 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按产品，2018-2030
    • 依最终用途，2018-2030 年
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
  • 亚太地区
    • 按产品，2018-2030
    • 依最终用途，2018-2030 年
    • 中国
    • 印度
    • 日本
    • 韩国
  • 拉丁美洲
    • 按产品，2018-2030
    • 依最终用途，2018-2030 年
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 按产品，2018-2030
    • 依最终用途，2018-2030 年
    • 沙乌地阿拉伯
    • 南非

第七章竞争格局

  • 主要市场参与企业的近期动态
  • 公司分类
  • 公司热图分析
  • 2024年企业市场定位分析
  • 战略地图
  • 公司简介/列表
    • Merck KGaA
    • Shreeneel Chemicals
    • Emeron Electric Co.
    • Luye Pharma Group
    • Argana Group
    • IOL Chemicals &Pharmaceuticals Ltd
    • AR Lifesciences
    • ALLCHEM LIFESCIENCE PVT. LTD.
    • AstraZeneca
    • Shreeneel Chemicals
    • Aether Industries
Product Code: GVR-4-68040-543-8

Quetiapine Intermediate Chemicals Market Growth & Trends:

The global quetiapine intermediate chemicals market size is anticipated to reach USD 65.8 billion by 2030 and is anticipated to grow at a CAGR of 4.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary driver is the rising global incidence of mental health disorders, increasing quetiapine demand, and thus the need for its intermediates. The cost-effectiveness of generic quetiapine production, especially in emerging markets, directly fuels demand for efficient intermediate synthesis. Pharmaceutical innovation, including new formulations and delivery systems, also necessitates a steady supply of these chemical building blocks.

The global burden of mental illnesses, such as schizophrenia and bipolar disorder, is a significant driver. Increased awareness and diagnosis contribute to a higher demand for effective treatments like quetiapine. Stressful lifestyles, socioeconomic factors, and aging populations are all contributing to the rising prevalence of mental health disorders.

The expiration of patents on branded quetiapine has opened the market to generic drug manufacturers. This has led to increased competition and a focus on cost-effective production, which directly impacts the demand for affordable intermediate chemicals. Pharmaceutical companies are continuously researching and developing new formulations of quetiapine, such as extended-release versions and novel delivery systems. This research and development activity requires a consistent supply of high-quality intermediates.

The increased prevalence of mental health disorders directly drives pharmaceutical demand for quetiapine, thus escalating the need for its intermediate chemicals. The push for cost-effective generic drug manufacturing compels pharma companies to source these intermediates efficiently. Pharmaceutical R&D efforts focusing on novel quetiapine formulations and delivery systems further contribute to the rising demand for these crucial chemical building blocks.

The Asia-Pacific region is experiencing rapid growth in its pharmaceutical sector, driven by increasing healthcare expenditure and a rising prevalence of mental health disorders, significantly boosting quetiapine demand. The region's strong focus on generic drug manufacturing, aimed at providing affordable medications, directly amplifies the need for cost-effective quetiapine intermediates. Additionally, increasing investments in local pharmaceutical research and development across APAC further contribute to the growing demand for these crucial chemical precursors.

Quetiapine Intermediate Chemicals Market Report Highlights:

  • Based on end use, the pharmaceuticals segment is expected to have the largest revenue share of 85.5% in 2024. The rising prevalence of mental health disorders, such as schizophrenia and bipolar disorder, is driving increased demand for quetiapine, consequently boosting the need for its intermediate chemicals.
  • Based on product, the Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one segment accounted for the largest revenue share of 35.2% in 2024 and is expected to continue to dominate the industry over the forecast period. It is a fundamental intermediate in quetiapine synthesis, forming the core ring structure. Its production efficiency directly impacts quetiapine output, thus influencing the demand for all upstream intermediates
  • Based on region, Asia-Pacific dominated with a revenue share of 50.7% in 2024. The rapidly growing pharmaceutical industry in the Asia-Pacific region, driven by increasing healthcare expenditure and a rising prevalence of mental health disorders, fuels demand for quetiapine intermediates.
  • In December 2024, Ami Organics Ltd. commenced construction of a second production line at its Cangzhou facility in Hebei Province, China, to manufacture the multifunctional additive Nylostab S-EED. This expansion, in partnership with Beijing Tiangang Auxiliary Co., Ltd., aims to meet the increasing demand from China's nylon industry, particularly in the textiles, automotive, and packaging sectors.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Information Analysis
    • 1.3.2. Market Formulation & Data Visualization
    • 1.3.3. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Global Quetiapine Intermediate Chemicals Market Outlook
  • 3.2. Value Chain Analysis
    • 3.2.1. Raw Material Outlook
    • 3.2.2. Industrial Refrigeration/Product Outlook
    • 3.2.3. Sales Channel Analysis
  • 3.3. Price Trend Analysis
    • 3.3.1. Factors Influencing Prices
  • 3.4. Regulatory Framework
    • 3.4.1. Standards & Compliances
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
    • 3.5.2. Market Restraint Analysis
    • 3.5.3. Market Challenges Analysis
    • 3.5.4. Market Opportunity Analysis
  • 3.6. Porter's Five Forces Analysis
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of Substitution
    • 3.6.4. Threat of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTLE Analysis
    • 3.7.1. Political
    • 3.7.2. Economic
    • 3.7.3. Social Landscape
    • 3.7.4. Product
    • 3.7.5. Environmental
    • 3.7.6. Legal

Chapter 4. Quetiapine Intermediate Chemicals Market: Product Estimates & Trend Analysis

  • 4.1. Quetiapine Intermediate Chemicals Market: Product Movement Analysis, 2024 & 2030
  • 4.2. 1-[2-(2-Hydroxyethoxy) ethyl]Piperazine
    • 4.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.3. Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one
    • 4.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4. Other Products
    • 4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Quetiapine Intermediate Chemicals Market: End Use Estimates & Trend Analysis

  • 5.1. Quetiapine Intermediate Chemicals Market: End Use Movement Analysis, 2024 & 2030
  • 5.2. Pharmaceuticals
    • 5.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.3. Other End Uses
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Quetiapine Intermediate Chemicals Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Analysis, 2024 & 2030
  • 6.2. North America
    • 6.2.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
    • 6.2.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.4. U.S.
      • 6.2.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.2.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.5. Canada
      • 6.2.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.2.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.2.6. Mexico
      • 6.2.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.2.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.2.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
    • 6.3.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.4. Germany
      • 6.3.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.3.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.5. UK
      • 6.3.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.3.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.6. France
      • 6.3.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.3.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.7. Italy
      • 6.3.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.3.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.3.8. Spain
      • 6.3.8.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.3.8.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.3.8.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
    • 6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.4. China
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.4.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.5. India
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.4.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.6. Japan
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.4.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.4.7.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.4.7.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
    • 6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.5.4. Brazil
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.5.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.5.5. Argentina
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.5.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.5.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa
    • 6.6.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
    • 6.6.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.6.4. Saudi Arabia
      • 6.6.4.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.6.4.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.6.4.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. Market estimates and forecasts, 2018 - 2030 (USD Million)
      • 6.6.5.2. Market estimates and forecasts, by product, 2018 - 2030 (USD Million)
      • 6.6.5.3. Market estimates and forecasts, by end use, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Market Positioning Analysis, 2024
  • 7.5. Strategy Mapping
  • 7.6. Company Profiles/Listing
    • 7.6.1. Merck KGaA
      • 7.6.1.1. Company Overview
      • 7.6.1.2. Financial Performance
      • 7.6.1.3. Product Benchmarking
    • 7.6.2. Shreeneel Chemicals
      • 7.6.2.1. Company Overview
      • 7.6.2.2. Financial Performance
      • 7.6.2.3. Product Benchmarking
    • 7.6.3. Emeron Electric Co.
      • 7.6.3.1. Company Overview
      • 7.6.3.2. Financial Performance
      • 7.6.3.3. Product Benchmarking
    • 7.6.4. Luye Pharma Group
      • 7.6.4.1. Company Overview
      • 7.6.4.2. Financial Performance
      • 7.6.4.3. Product Benchmarking
    • 7.6.5. Argana Group
      • 7.6.5.1. Company Overview
      • 7.6.5.2. Financial Performance
      • 7.6.5.3. Product Benchmarking
    • 7.6.6. IOL Chemicals & Pharmaceuticals Ltd
      • 7.6.6.1. Company Overview
      • 7.6.6.2. Financial Performance
      • 7.6.6.3. Product Benchmarking
    • 7.6.7. AR Lifesciences
      • 7.6.7.1. Company Overview
      • 7.6.7.2. Financial Performance
      • 7.6.7.3. Product Benchmarking
    • 7.6.8. ALLCHEM LIFESCIENCE PVT. LTD.
      • 7.6.8.1. Company Overview
      • 7.6.8.2. Financial Performance
      • 7.6.8.3. Product Benchmarking
    • 7.6.9. AstraZeneca
      • 7.6.9.1. Company Overview
      • 7.6.9.2. Financial Performance
      • 7.6.9.3. Product Benchmarking
    • 7.6.10. Shreeneel Chemicals
      • 7.6.10.1. Company Overview
      • 7.6.10.2. Financial Performance
      • 7.6.10.3. Product Benchmarking
    • 7.6.11. Aether Industries
      • 7.6.11.1. Company Overview
      • 7.6.11.2. Financial Performance
      • 7.6.11.3. Product Benchmarking

List of Tables

  • Table 1 Quetiapine Intermediate Chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Table 2 1-[2-(2-Hydroxyethoxy) ethyl] Piperazine quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Table 3 Dibenzo[b,f][1,4]thiazepin 11 (10 H)-one quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Table 4 Other product quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Table 5 Quetiapine intermediate chemicals market estimates & forecasts, by pharmaceuticals, 2018 - 2030 (Kilotons) (USD Million)
  • Table 6 Quetiapine intermediate chemicals market estimates & forecasts, by other end uses, 2018 - 2030 (Kilotons) (USD Million)
  • Table 7 Quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (USD Million)
  • Table 8 Quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 9 Quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD Million)
  • Table 10 Quetiapine Intermediate Chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 11 Quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 12 North America polyurethane Coatings market estimates & forecast, 2018 - 2030 (Kilotons) (USD Million)
  • Table 13 North America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 14 North America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD Million)
  • Table 15 North America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 16 North America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD Million)
  • Table 17 U.S. quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD Million)
  • Table 18 U.S. quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 19 U.S. quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 20 U.S. quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 21 U.S. quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 22 Canada quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 23 Canada quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 24 Canada quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 25 Canada quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 26 Canada quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 27 Mexico quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 28 Mexico quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 29 Mexico quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 30 Mexico quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 31 Mexico quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 32 Europe quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 33 Europe quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 34 Europe quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 35 Europe quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 36 Europe quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 37 Germany quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 38 Germany quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 39 Germany quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 40 Germany quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 41 Germany quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 42 UK quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 43 UK quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 44 UK quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 45 UK quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 46 UK quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 47 France quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 48 France quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 49 France quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 50 France quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 51 France quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 52 Italy quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 53 Italy quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 54 Italy quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 55 Italy quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 56 Italy quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 57 Spain quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 58 Spain quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 59 Spain quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 60 Spain quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 61 Spain quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 62 Asia pacific quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 63 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 64 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 65 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 66 Asia pacific quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 67 China quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
  • Table 68 China quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 69 China quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 70 China quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 71 China quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 72 India quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
  • Table 73 India quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 74 India quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 75 India quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 76 India quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 77 Japan quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
  • Table 78 Japan quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 79 Japan quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 80 Japan quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 81 Japan quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 82 South Korea quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
  • Table 83 South Korea quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 84 South Korea quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 85 South Korea quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 86 South Korea quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 87 Latin America quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 88 Latin America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 89 Latin America quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 90 Latin America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 91 Latin America quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 92 Brazil quetiapine intermediate chemicals market estimates & forecast, 2018 - 2030 (Kilotons) (USD million)
  • Table 93 Brazil quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 94 Brazil quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 95 Brazil quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 96 Brazil quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 97 Argentina quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 98 Argentina quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 99 Argentina quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 100 Argentina quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 101 Argentina quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 102 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 103 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 104 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 105 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 106 Middle East & Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 107 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 108 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 109 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 110 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 111 Saudi Arabia quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)
  • Table 112 South Africa quetiapine intermediate chemicals market estimates & forecasts, 2018 - 2030 (Kilotons) (USD million)
  • Table 113 South Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (Kilotons)
  • Table 114 South Africa quetiapine intermediate chemicals market estimates & forecasts by product, 2018 - 2030 (USD million)
  • Table 115 South Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (Kilotons)
  • Table 116 South Africa quetiapine intermediate chemicals market estimates & forecasts by end use, 2018 - 2030 (USD million)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market snapshot
  • Fig. 7 Segmental outlook - End Use & Product
  • Fig. 8 Competitive Outlook
  • Fig. 9 Quetiapine Intermediate Chemicals market outlook, 2018 - 2030 (USD Million)
  • Fig. 10 Value chain analysis
  • Fig. 11 Market dynamics
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTEL Analysis
  • Fig. 14 Quetiapine Intermediate Chemicals market, by product: Key takeaways
  • Fig. 15 Quetiapine Intermediate Chemicals market, by product: Market share, 2024 & 2030
  • Fig. 16 Quetiapine Intermediate Chemicals market, by end use: Key takeaways
  • Fig. 17 Quetiapine Intermediate Chemicals market, by end use: Market share, 2024 & 2030
  • Fig. 18 Quetiapine Intermediate Chemicals market: regional analysis, 2024
  • Fig. 19 Quetiapine Intermediate Chemicals market, by region: Key takeaways